Lecturer @UCL @School_Pharmacy | CStat, FHEA, FRSPH | #RxEpi | #ADHD | Exploring the world with data | Prenatal, Children & Mental health | Views are my own

London, England
Honored with the Kramer-Pollnow Prize by @eunethydis! A heartfelt thank you to the organisation and to the brilliant minds in the field who inspire me every day. Grateful for this incredible recognition. #KramerPollnowPrize #ADHD
4
5
30
2,317
Kenneth Man retweeted
📰 Very happy to share that my first paper is now published in The Lancet Healthy Longevity. In this target trial emulation study, we looked at whether stopping long-term antipsychotic treatment is safe for older adults living with dementia. 🔗 thelancet.com/journals/lanhl…
3
4
8
928
Kenneth Man retweeted
Our study using data from the UK CPRD Aurum published in @CIDJournal shows that metformin use within 90 days of COVID-19 diagnosis reduces post-COVID risk in individuals with overweight/obesity. 📮Read more: doi.org/10.1093/cid/ciaf429 @ChengshengJ @LiWeiUCL @KennethKCMan
3
3
342
Kenneth Man retweeted
Our multinational network cohort study shows that extensive multi-organ involvement of post-COVID-19 condition over the short-term period and the subside in risk for most complications over the medium- and long-term. journals.sagepub.com/doi/10.…
38
18
956
🌍 Exciting PhD studentship at UCL School of Pharmacy! Join the GENESIS project, a global collaboration using real-world data to advance mental health & maternal-child health research. #PhD #Epidemiology #RegulatoryScience 🔗 ucl.ac.uk/pharmacy/study/mph…
4
6
325
The fifth and final member of our OPERA 2025 shortlist, @wallis_lau, was lauded by judges for her research’s influence on prescribing recommendations, ensuring safer anticoagulant use. Read more here: pharmaceutical-journal.com/a… The overall winner will be announced on 30 June 2025 🏆
3
7
665
Kenneth Man retweeted
Our latest multinational study on trends in survival after #Dementia diagnosis has just been published with @SpringerNature in @CommsMedicine Read here: rdcu.be/eocfU @Ian_HKU @ChuiCeline @KennethKCMan @Knappem @GloW_hk
52
23
1,124
Kenneth Man retweeted
The findings of this new study do not support a direct effect of gabapentinoid treatment on self-harm but underscore the necessity for close patient monitoring of self-harm throughout the gabapentinoid treatment journey @KennethKCMan bmj.com/content/389/bmj-2024…
3
8
6,112
Kenneth Man retweeted
Treatment with gabapentinoids isn't directly associated with an increased risk of self-harm, finds this study. However, rates of self-harm were higher before and shortly after treatment, highlighting the need for close monitoring of patients @KennethKCMan bmj.com/content/389/bmj-2024…
6
6
4,296
Kenneth Man retweeted
🧠 #TIMESPAN is transforming #ADHD research. By uniting global data, we explore ADHD's impact on cardiometabolic conditions, capture treatment variations, and drive better outcomes worldwide. #ADHDResearch #GlobalHealth ➡ Full blog post: timespan.eu/healthcare-data-…
1
4
3
411
PhD Opportunity @UCL 🌍 Join our global collaboration with SKKU & partners, tackling key health challenges in mental health & maternal-child health using real-world data! 💡 Open to passionate candidates in epidemiology, stats, pharmacy & more! @FindAPhD: findaphd.com/phds/projectdet…
4
6
408
🚨 'Prescribing of antipsychotics for people diagnosed with severe mental illness in UK primary care 2000–2019: 20-year investigation of who receives treatment, with which agents and at what doses' now published in @TheBJPsych doi.org/10.1192/bjp.2024.186
1
9
21
1,417
Metformin was associated with a lower rate of asthma attacks, with further reductions with the use of GLP-1RA. ja.ma/3UQckFp
7
52
181
137,706
A very nice study by @BoheeLEE4 and @chloebloom using multiple study designs (self-controlled case series & cohort analysis) showed consistent results: metformin lowered asthma attack risk by ~30%, with GLP-1RA adding 40%. A robust approach to observational data!
4
257
Great study lead by @fredho42 looked into factors contributing to the association between deprivation and infant death. Targeting moderating factors may mitigate some the effects but will not stem the rise in infant mortality. #heathinequalities sciencedirect.com/science/ar…
2
4
322
I was an ad-hoc reviewer in June 2023 and then was invited to be an ERC core member in Feb 2024. Happy to take one step further as ERC chair for CPRD.
2
14
513
Our new @OHDSI study in Lancet Psychiatry found that the prescribing rates of anxiolytics during the COVID-19 pandemic were persistently elevated, underscore the importance of enhanced mental health support and regular review of psychotropic drug use in the post-pandemic era.
1
15
16
1,616